Pearland recognized by Healthgrades as national leader in specialty care

Pearland, TX — HCA Houston Healthcare Pearland achieved accolades for clinical excellence from Healthgrades, the #1 site Americans use when searching for a doctor or hospital. HCA Houston Healthcare Pearland’s distinctions include being rated a Five-Star Recipient for Pacemaker Procedures for 2025 and a Five-Star Recipient for Treatment of Sepsis for the second year in a row (2024-2025). 

HCA Houston Healthcare Pearland’s achievements are based solely on what matters most: patient outcomes. As part of its 2025 hospital assessment, Healthgrades evaluated risk-adjusted mortality and complication rates for over 30 of the most common conditions and procedures at approximately 4,500 hospitals nationwide to determine the top performers in specialty care. By offering easy access to objective performance measures, Healthgrades helps consumers find and select a hospital that excels in providing the care they need. 

As variation in performance among hospitals continues to grow, it is increasingly important for consumers to seek care at top-rated programs. Healthgrades’ 2025 analysis revealed that if all hospitals as a group performed similarly to five-star hospitals during the 2021-2023 study period, on average, 224,958 lives could potentially have been saved and 141,692 complications could potentially have been avoided.* 

“Healthgrades commends HCA Houston Healthcare Pearland for their clear commitment to delivering consistently superior patient outcomes in critical service areas,” said Brad Bowman, MD, chief medical officer and head of data science at Healthgrades. “The hospital’s leadership, expertise, and unwavering dedication to clinical excellence set a high mark for specialty care in Texas and nationwide.” 

Consumers can visit healthgrades.com to learn more about how Healthgrades measures hospital quality and access a patient-friendly overview of how we rate and why hospital quality matters here. 

*Statistics are based on Healthgrades analysis of MedPAR data for years 2021 through 2023 and represent three-year estimates for Medicare patients only. Click here to view the complete 2025 Specialty Awards and Ratings Methodology.